Capital Investment Counsel Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $329K | Sell |
5,713
-100
| -2% | -$5.74K | 0.04% | 164 |
|
|
2026
Q1 | $353K | Buy |
5,813
+894
| +18% | +$52.1K | 0.04% | 147 |
|
|
2025
Q4 | $265K | Sell |
4,919
-800
| -14% | -$38.5K | 0.03% | 169 |
|
|
2025
Q3 | $258K | Buy |
5,719
+130
| +2% | +$6.07K | 0.03% | 170 |
|
|
2025
Q2 | $259K | Buy |
5,589
+465
| +9% | +$22.8K | 0.03% | 164 |
|
|
2025
Q1 | $313K | Hold |
5,124
| – | – | 0.05% | 150 |
|
|
2024
Q4 | $290K | Sell |
5,124
-155
| -3% | -$8.66K | 0.04% | 151 |
|
|
2024
Q3 | $273K | Buy |
5,279
+55
| +1% | +$2.58K | 0.04% | 156 |
|
|
2024
Q2 | $217K | Buy |
5,224
+68
| +1% | +$3.04K | 0.03% | 172 |
|
|
2024
Q1 | $280K | Sell |
5,156
-101
| -2% | -$5.14K | 0.05% | 152 |
|
|
2023
Q4 | $270K | Sell |
5,257
-350
| -6% | -$18.4K | 0.05% | 147 |
|
|
2023
Q3 | $325K | Hold |
5,607
| – | – | 0.07% | 130 |
|
|
2023
Q2 | $359K | Buy |
5,607
+101
| +2% | +$6.77K | 0.07% | 125 |
|
|
2023
Q1 | $382K | Hold |
5,506
| – | – | 0.09% | 117 |
|
|
2022
Q4 | $396K | Buy |
5,506
+1,256
| +30% | +$94.7K | 0.09% | 117 |
|
|
2022
Q3 | $302K | Sell |
4,250
-1,756
| -29% | -$127K | 0.09% | 120 |
|
|
2022
Q2 | $462K | Sell |
6,006
-1,700
| -22% | -$129K | 0.12% | 107 |
|
|
2022
Q1 | $563K | Sell |
7,706
-150
| -2% | -$10.1K | 0.12% | 106 |
|
|
2021
Q4 | $490K | Sell |
7,856
-400
| -5% | -$23.5K | 0.09% | 121 |
|
|
2021
Q3 | $489K | Sell |
8,256
-750
| -8% | -$49.4K | 0.11% | 107 |
|
|
2021
Q2 | $602K | Hold |
9,006
| – | – | 0.13% | 92 |
|
|
2021
Q1 | $569K | Buy |
9,006
+2,356
| +35% | +$147K | 0.15% | 88 |
|
|
2020
Q4 | $412K | Sell |
6,650
-2,356
| -26% | -$145K | 0.13% | 89 |
|
|
2020
Q3 | $543K | Buy |
9,006
+2,356
| +35% | +$142K | 0.16% | 85 |
|
|
2020
Q2 | $391K | Sell |
6,650
-2,356
| -26% | -$141K | 0.15% | 85 |
|
|
2020
Q1 | $502K | Sell |
9,006
-867
| -9% | -$53K | 0.2% | 77 |
|
|
2019
Q4 | $634K | Buy |
9,873
+567
| +6% | +$32.5K | 0.2% | 84 |
|
|
2019
Q3 | $472K | Hold |
9,306
| – | – | 0.17% | 93 |
|
|
2019
Q2 | $422K | Buy |
9,306
+3,150
| +51% | +$147K | 0.15% | 101 |
|
|
2019
Q1 | $294K | Hold |
6,156
| – | – | 0.11% | 121 |
|
|
2018
Q4 | $320K | Buy |
6,156
+200
| +3% | +$10.7K | 0.14% | 101 |
|
|
2018
Q3 | $370K | Sell |
5,956
-1,500
| -20% | -$89K | 0.14% | 102 |
|
|
2018
Q2 | $413K | Buy |
7,456
+4,000
| +116% | +$216K | 0.16% | 92 |
|
|
2018
Q1 | $219K | Hold |
3,456
| – | – | 0.09% | 133 |
|
|
2017
Q4 | $212K | Sell |
3,456
-400
| -10% | -$25K | 0.09% | 135 |
|
|
2017
Q3 | $246K | Sell |
3,856
-600
| -13% | -$35K | 0.11% | 124 |
|
|
2017
Q2 | $248K | Hold |
4,456
| – | – | 0.11% | 126 |
|
|
2017
Q1 | $242K | Buy |
+4,456
| New | +$244K | 0.11% | 128 |
|
Other funds holding BMY
Capital Investment Counsel Inc's BMY Position: Q2 2026 in Review
Capital Investment Counsel Inc reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $5.74K and leaving 5,713 shares worth $329K. The position accounts for 0.04% of the portfolio, ranked #164.
Capital Investment Counsel Inc first reported a position in BMY in Q1 2017 and has held it in 38 quarters since. The position peaked at $634K in Q4 2019. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Capital Investment Counsel Inc held 5,713 shares of Bristol-Myers Squibb worth $329K as of Q2 2026.
- Capital Investment Counsel Inc sold 100 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74K.
- Bristol-Myers Squibb made up 0.04% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #164 holding.
- Capital Investment Counsel Inc first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 38 quarters since.
- Capital Investment Counsel Inc's Bristol-Myers Squibb position peaked at $634K in Q4 2019.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.